Get complete Patent Opposition Report for Innate Pharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Innate Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3405495Feb 24, 2021Neutralization Of Inhibitory Pathways In Lymphocytes1
EP3191517Nov 4, 2020Cross Reactive Siglec Antibodies1